Status:
COMPLETED
Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cardiometabolic Risk
Abdominal Obesity
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
The aim of this study is to demonstrate the beneficial effects on gut microbiota composition and activity of the diary intake of insoluble fiber (extract from Aspergillus Niger) for three weeks. The f...
Eligibility Criteria
Inclusion
- Healthy
- Non-smokers
- Body mass index between 25 and 35 kg/m2
- Waist circumference \< 80cm for women and \> 94 cm for men
- Fiber intake \<25g/day
Exclusion
- Medical history of digestive surgery or disease
- Current or recent (\<12 weeks) intake of antibiotics or gastro-intestinal medicinal product
- Current probiotics, prebiotics, fiber complement, and/or any products modulation gut transit
- Feeding particular diet such as vegetarian diet or hyperprotein diet
- Current weight loss diet
- Pregnant or lactating woman or woman who did not use effective contraception
- Drinking more than 3 glasses of alcohol per day (\>30g/day)
Key Trial Info
Start Date :
November 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2019
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03773900
Start Date
November 7 2018
End Date
June 6 2019
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherche en Nutrition Humaine Rhône-Alpes - Centre hospitalier Lyon Sud
Pierre-Bénite, France, 69310